Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis
J Clin Invest
.
2024 Mar 15;134(6):e180583.
doi: 10.1172/JCI180583.
Authors
Dennis G Moledina
,
Wassim Obeid
,
Rex N Smith
,
Ivy Rosales
,
Meghan E Sise
,
Gilbert Moeckel
,
Michael Kashgarian
,
Michael Kuperman
,
Kirk N Campbell
,
Sean Lefferts
,
Kristin Meliambro
,
Markus Bitzer
,
Mark A Perazella
,
Randy L Luciano
,
Jordan S Pober
,
Lloyd G Cantley
,
Robert B Colvin
,
F Perry Wilson
,
Chirag R Parikh
PMID:
38488004
PMCID:
PMC10940080
DOI:
10.1172/JCI180583
No abstract available
MeSH terms
Acute Disease
Biomarkers
Chemokine CXCL9
Humans
Nephritis, Interstitial* / diagnosis
Substances
Biomarkers
CXCL9 protein, human
Chemokine CXCL9
Supplementary concepts
Acute Tubulointerstitial Nephritis
Grants and funding
P30 DK020572/DK/NIDDK NIH HHS/United States